Laird-Offringa I A, de Wit C L, Elfferich P, van der Eb A J
Laboratory for Molecular Carcinogenesis, Sylvius Laboratories, University of Leiden, The Netherlands.
Mol Cell Biol. 1990 Dec;10(12):6132-40. doi: 10.1128/mcb.10.12.6132-6140.1990.
The highly unstable c-myc mRNA has been shown to be stabilized in cells treated with protein synthesis inhibitors. We have studied this phenomenon in an effort to gain more insight into the degradation pathway of this mRNA. Our results indicate that the stabilization of c-myc mRNA in the absence of translation can be fully explained by the inhibition of translation-dependent poly(A) tail shortening. This view is based on the following observations. First, the normally rapid shortening of the c-myc poly(A) tail was slowed down by a translation block. Second, c-myc messengers which carry a short poly(A) tail, as a result of prolonged actinomycin D or 3'-deoxyadenosine treatment, were not stabilized by the inhibition of translation. We propose that c-myc mRNA degradation proceeds in at least two steps. The first step is the shortening of long poly(A) tails. This step requires ongoing translation and thus is responsible for the delay in mRNA degradation observed in the presence of protein synthesis inhibitors. The second step involves rapid degradation of the body of the mRNA, possibly preceded by the removal of the short remainder of the poly(A) tail. This last step is independent of translation.
高度不稳定的c-myc mRNA已被证明在用蛋白质合成抑制剂处理的细胞中会被稳定下来。我们研究了这一现象,以期更深入地了解该mRNA的降解途径。我们的结果表明,在没有翻译的情况下c-myc mRNA的稳定可以完全通过抑制翻译依赖性的多聚腺苷酸(poly(A))尾巴缩短来解释。这一观点基于以下观察结果。首先,翻译阻断减缓了c-myc多聚腺苷酸尾巴正常快速的缩短。其次,由于长时间放线菌素D或3'-脱氧腺苷处理而带有短多聚腺苷酸尾巴的c-myc信使RNA,不会因翻译抑制而稳定。我们提出,c-myc mRNA降解至少分两步进行。第一步是长多聚腺苷酸尾巴的缩短。这一步需要持续翻译,因此是蛋白质合成抑制剂存在时观察到的mRNA降解延迟的原因。第二步涉及mRNA主体的快速降解,可能在去除多聚腺苷酸尾巴的短剩余部分之前。最后这一步与翻译无关。